Patent Number: 7,045,361

Title: Analyte sensing via acridine-based boronate biosensors

Abstract: Fluorescent biosensor molecules, fluorescent biosensors and systems, as well as methods of making and using these biosensor molecules and systems are described. These biosensor molecules address the problem of obtaining fluorescence emission at wavelengths greater than about 500 nm. Biosensor molecules generally include an (1) an acridine-based fluorophore, (2) a linker moiety and (3) a boronate substrate recognition/binding moiety, which binds polyhydroxylate analytes, such as glucose. These biosensor molecules further include a "switch" element that is drawn from the electronic interactions among these submolecular components. This fluorescent switch is generally "off" in the absence of bound polyhydroxylate analyte and is generally "on" in the presence of bound polyhydroxylate analyte. Thus, the reversible binding of a polyhydroxylate analyte essentially turns the fluorescent switch "on" and "off". This property of the biosensor molecules, as well as their ability to emit fluorescent light at greater than about 500 nm, renders these biosensor molecules particularly well-suited for detecting and measuring in-vivo glucose concentrations.

Inventors: Heiss; Aaron M. (Sherman Oaks, CA), Walsh; Joseph C. (Los Angeles, CA), Vachon; David J. (Granada Hills, CA), Noronha; Glenn (Oceanside, CA), Reilly; Jonathan (Reseda, CA), Ponder; Bill C. (Fort Worth, TX), Van Antwerp; William P. (Valencia, CA)

Assignee: Medtronic MiniMed, Inc.

International Classification: G01N 21/64 (20060101); G01N 33/58 (20060101); G01N 33/66 (20060101)

Expiration Date: 5/16/02018